$VRNS
VARONIS SYSTEMS INC Stock $vrns

$vrns Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000162828023026463 Filed on August 01, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$122.3M	$115.4M
YoY Change	-0.81%	3.56%
Cost Of Revenue	$17.38M	$17.39M
YoY Change	1.06%	-2.32%
Gross Profit	$104.9M	$98.03M
YoY Change	-1.11%	4.68%
Gross Profit Margin	85.79%	84.94%
Selling, General & Admin	$89.26M	$91.60M
YoY Change	2.34%	6.02%
% of Gross Profit	85.06%	93.44%
Research & Development	$44.82M	$46.14M
YoY Change	0.76%	2.97%
% of Gross Profit	42.71%	47.07%
Depreciation & Amortization	$2.930M	$2.916M
YoY Change	-0.61%	16.73%
% of Gross Profit	2.79%	2.97%
Operating Expenses	$134.1M	$137.7M
YoY Change	1.81%	4.98%
Operating Profit	-$29.15M	-$39.72M
YoY Change	13.94%	5.72%
Interest Expense	$8.600M	$8.465M
YoY Change	253.76%	184.44%
% of Operating Profit
Other Income/Expense, Net	$8.634M	$8.465M
YoY Change	255.16%	184.44%
Pretax Income	-$20.51M	-$31.25M
YoY Change	-11.39%	-9.66%
Income Tax	$2.504M	$7.446M
% Of Pretax Income
Net Earnings	-$23.02M	-$38.70M
YoY Change	-19.85%	6.63%
Net Earnings / Revenue	-18.82%	-33.53%
Basic Earnings Per Share	-$0.21	-$0.35
Diluted Earnings Per Share	-$0.21	-$0.35
COMMON SHARES
Basic Shares Outstanding	109.6M shares	109.7M shares
Diluted Shares Outstanding	109.4M shares	109.7M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$525.1M	$753.8M
YoY Change	-33.56%	-4.44%
Cash & Equivalents	$111.2M	$399.2M
Short-Term Investments	$413.9M	$354.6M
Other Short-Term Assets	$49.90M	$47.90M
YoY Change	44.4%	41.3%
Inventory
Prepaid Expenses
Receivables	$111.1M	$103.7M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$686.1M	$905.3M
YoY Change	-25.15%	-0.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$34.40M	$90.52M
YoY Change	-9.93%	128.38%
Goodwill	$23.14M	$23.14M
YoY Change	0.0%	0.0%
Intangibles	$1.644M	$2.025M
YoY Change	-48.12%	-42.96%
Long-Term Investments	$206.4M
YoY Change
Other Assets	$16.33M	$15.89M
YoY Change	-12.5%	-15.77%
Total Long-Term Assets	$334.6M	$131.6M
YoY Change	135.79%	-9.7%
TOTAL ASSETS
Total Short-Term Assets	$686.1M	$905.3M
Total Long-Term Assets	$334.6M	$131.6M
Total Assets	$1.021B	$1.037B
YoY Change	-3.57%	-1.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.328M	$680.0K
YoY Change	-77.83%	-85.71%
Accrued Expenses	$119.8M	$123.3M
YoY Change	9.66%	16.6%
Deferred Revenue	$145.5M	$130.7M
YoY Change	54.43%	32.89%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$266.6M	$254.8M
YoY Change	27.28%	21.94%
LONG-TERM LIABILITIES
Long-Term Debt	$250.1M	$249.7M
YoY Change	0.61%	0.6%
Other Long-Term Liabilities	$7.891M	$61.72M
YoY Change	9.73%	1280.1%
Total Long-Term Liabilities	$309.6M	$311.4M
YoY Change	-2.27%	-1.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$266.6M	$254.8M
Total Long-Term Liabilities	$309.6M	$311.4M
Total Liabilities	$576.1M	$566.2M
YoY Change	9.49%	7.67%
SHAREHOLDERS EQUITY
Retained Earnings	-$643.5M	-$620.5M
YoY Change	20.79%	23.11%
Common Stock	$109.0K	$110.0K
YoY Change	-0.91%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$444.6M	$470.7M
YoY Change
Total Liabilities & Shareholders Equity	$1.021B	$1.037B
YoY Change	-3.57%	-1.46%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$23.02M	-$38.70M
YoY Change	-19.85%	6.63%
Depreciation, Depletion And Amortization	$2.930M	$2.916M
YoY Change	-0.61%	16.73%
Cash From Operating Activities	$6.330M	$5.806M
YoY Change	-486.45%	-140.13%
INVESTING ACTIVITIES
Capital Expenditures	$350.0K	$1.493M
YoY Change	-123.33%	-156.57%
Acquisitions
YoY Change
Other Investing Activities	-$263.0M	$153.9M
YoY Change	50572.45%	-2929.36%
Cash From Investing Activities	-$263.3M	$152.4M
YoY Change	12943.09%	-1986.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-31.00M	-7.619M
YoY Change	-755.39%	761800.0%
NET CHANGE
Cash From Operating Activities	6.330M	5.806M
Cash From Investing Activities	-263.3M	152.4M
Cash From Financing Activities	-31.00M	-7.619M
Net Change In Cash	-288.0M	150.6M
YoY Change	-26941.57%	-767.99%
FREE CASH FLOW
Cash From Operating Activities	$6.330M	$5.806M
Capital Expenditures	$350.0K	$1.493M
Free Cash Flow	$5.980M	$4.313M
YoY Change	-4433.33%	-136.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
CY2023Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q2	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2032-12-31
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y10M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y5M23D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y5M15D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y5M23D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y5M15D
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	53919000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	56772000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36602000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39043000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2025000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2788000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	23135000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	23135000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15888000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16337000	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	131569000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	138075000	usd
CY2023Q2	us-gaap	Assets Assets	1036893000	usd
CY2022Q4	us-gaap	Assets Assets	1043732000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	680000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2962000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	123343000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	115231000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	130727000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	110550000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	254750000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	228743000	usd
CY2023Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	249716000	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	248963000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	53565000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	57627000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	648000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1503000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7505000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4771000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	311434000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	312864000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	109818559	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	109818559	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	110000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	108000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-18019000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-9557000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1109093000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1055048000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-620475000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-543474000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	470709000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	502125000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1036893000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1043732000	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	17386000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	17799000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	98032000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	93649000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	46144000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44815000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	70321000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	68714000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21283000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17688000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	137748000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	131217000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-39716000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-37568000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8465000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2976000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-31251000	usd
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109740289	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109740289	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109063722	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109063722	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-38697000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-36290000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-646000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-12000	usd
CY2023Q2	vrns	Other Comprehensive Income Loss Securities Availablefor Sale Gain Loss Netof Tax OtherComprehensiveIncomeLossSecuritiesAvailableforSaleGainLossNetofTax	-1000	usd
CY2022Q2	vrns	Other Comprehensive Income Loss Securities Availablefor Sale Gain Loss Netof Tax OtherComprehensiveIncomeLossSecuritiesAvailableforSaleGainLossNetofTax	3000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-647000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-9000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	311000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-11097000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	3302000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-293000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-2991000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-10804000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3638000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-10813000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-42335000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-47103000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	596593000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35998000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6111000	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	28825000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-3179000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-10000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-48763000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	535778000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	37758000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5000	usd
CY2022Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	6000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-10804000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-9000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-36290000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	526432000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	502125000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35811000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5853000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	16864000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2519000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-4980000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	156000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-38304000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	481278000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	39385000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	36000	usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2575000	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	5080000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-2991000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-647000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-38697000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	470709000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-77001000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5807000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	75196000	usd
	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	12524000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4731000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	754000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	2724000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-32311000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10065000	usd
	vrns	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	12423000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	447000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2282000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-5799000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	19322000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	2732000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	42636000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	20850000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	59698000	usd
	vrns	Proceeds From Short Term And Long Term Deposits ProceedsFromShortTermAndLongTermDeposits	162012000	usd
	vrns	Payments To Acquire Short Term And Long Term Deposits PaymentsToAcquireShortTermAndLongTermDeposits	110652000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2603000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9909000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	5889000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	19439000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7599000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	2400000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1611000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1159000	usd
CY2023Q2	vrns	Subsidiary Or Equity Method Investee Number SubsidiaryOrEquityMethodInvesteeNumber	12	subsidiary
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	74899000	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	195752000	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.70
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
	vrns	Contract With Customer Right Of Return Sales Returns ContractWithCustomerRightOfReturnSalesReturns	0	usd
CY2023Q1	vrns	Contract With Customer Right Of Return Sales Returns ContractWithCustomerRightOfReturnSalesReturns	0	usd
CY2023Q2	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P4Y
CY2023Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	145000	usd
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-155000	usd
CY2022Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	1819000	usd
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	2560000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7446000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1698000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10407000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3112000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	349381000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	349381000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	278022000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	278022000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	53919000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9691000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	53565000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	63256000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	5878000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10962000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	9627000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	9398000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9603000	usd
CY2023Q2	vrns	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	23670000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	69138000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5882000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	63256000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y10M20D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0280
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	2410000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	4702000	usd
CY2023Q2	us-gaap	Sublease Income SubleaseIncome	438000	usd
	us-gaap	Sublease Income SubleaseIncome	901000	usd
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	2291000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	4600000	usd
CY2022Q2	us-gaap	Sublease Income SubleaseIncome	198000	usd
	us-gaap	Sublease Income SubleaseIncome	298000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6110000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4085000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2025000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	381000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	381000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	762000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	762000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	762000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1263000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2025000	usd
CY2023Q2	vrns	Derivative Initial Cap Price DerivativeInitialCapPrice	47.24
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	691573	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.533
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	11347000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	42971	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.561
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	11235	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	5.560
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	637367	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.633
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	12121000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	633920	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.644
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	12048000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	836000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	91000	usd
CY2023Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	637367	shares
CY2023Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	7.633
CY2023Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	633920	shares
CY2023Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	7.644
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39384000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	37758000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	75195000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	73756000	usd
CY2022Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000	usd
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	3221724	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	64044000	usd
CY2023Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	35956000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	115418000	usd

Files In Submission

Name	View Source	Status
0001628280-23-026463-index-headers.html	Edgar Link	pending
0001628280-23-026463-index.html	Edgar Link	pending
0001628280-23-026463.txt	Edgar Link	pending
0001628280-23-026463-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vrns-20230630.htm	Edgar Link	pending
vrns-20230630.xsd	Edgar Link	pending
vrnsq22023exh102.htm	Edgar Link	pending
vrnsq22023exh103.htm	Edgar Link	pending
vrnsq22023exh104.htm	Edgar Link	pending
vrnsq22023exh105.htm	Edgar Link	pending
vrnsq22023exh311.htm	Edgar Link	pending
vrnsq22023exh312.htm	Edgar Link	pending
vrnsq22023exh321.htm	Edgar Link	pending
vrnsq22023exh322.htm	Edgar Link	pending
vrns-20230630_def.xml	Edgar Link	unprocessable
vrns-20230630_lab.xml	Edgar Link	unprocessable
vrns-20230630_pre.xml	Edgar Link	unprocessable
vrns-20230630_htm.xml	Edgar Link	completed
vrns-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VRNS
VARONIS SYSTEMS INC Stock $vrns

2023 Q3 Form 10-Q Financial Statement

#000162828023026463 Filed on August 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRNS VARONIS SYSTEMS INC Stock $vrns

2023 Q3 Form 10-Q Financial Statement

#000162828023026463 Filed on August 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRNS
VARONIS SYSTEMS INC Stock $vrns